Photo: Storyblocks.com |
In March, the IDx inventors were awarded the first-of-its-kind U.S. patent for an algorithm to automatically determine an arteriolar-to-venular diameter ratio (AVR) in blood vessels.
Primary Care Optometry News spoke with Michael D. Abramoff, MD, PhD, who oversees the IDx leadership team and is a fellowship-trained retina specialist with a PhD in image analysis and the Robert C. Watzke Professor of Ophthalmology and Visual Sciences at the University of Iowa Hospitals and Clinics.
Abramoff explained how he and his co-inventors harness artificial intelligence (AI) to allow for increased patient access to identify health risks while saving time and money.
Earlier this week, the FDA granted marketing approval for IDx-DR, the first artificial intelligence medical device to detect more than a mild level of diabetic retinopathy in adults with diabetes, as reported by Ocular Surgery News.
Read more...
Source: Healio